Design, synthesis and structure–activity relationships of azole acids as novel, potent dual PPAR α/γ agonists

Hao Zhang(Bristol-Myers Squibb (United States)), Peter T. W. Cheng(Bristol-Myers Squibb (United States)), Dennis Farrelly(Bristol-Myers Squibb (United States)), Thomas Harrity(Bristol-Myers Squibb (United States)), Lori Kunselman(Bristol-Myers Squibb (United States)), Lisa Moore(Bristol-Myers Squibb (United States)), Jonathan Lippy(Bristol-Myers Squibb (United States)), Nathan Morgan(Bristol-Myers Squibb (United States)), Michael Cap, Carrie Xu, Pratik Devasthale(Institut des Maladies Métaboliques et Cardiovasculaires), Lisa Zhang(The University of Sydney), Denis E. Ryono(Institut des Maladies Métaboliques et Cardiovasculaires), ChiehYing Chang(Bristol-Myers Squibb (Germany)), Pathanjali Kadiyala(Louisville Metabolic and Atherosclerosis Research Center), Narayanan Hariharan(Bristol-Myers Squibb (United States)), Robert Zahler(Institut des Maladies Métaboliques et Cardiovasculaires), Cuixia Chu(Bristol-Myers Squibb (United States)), J.K. Muckelbauer(Institute of Crystallography), Li‐Qun Gu(Texas A&M Health Science Center), Vinayak Hosagrahara, Kenneth T. Locke(Medicines Evaluation Unit), Wei Wang(Binzhou Medical University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Kevin O’Malley(Medicines Evaluation Unit), Neil Flynn(Bristol-Myers Squibb (United States)), Aneka Bell, Arthur M. Doweyko(Bristol-Myers Squibb (United States))
Bioorganic & Medicinal Chemistry Letters
January 16, 2009
Cited by 35


Related Papers